Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients

ClinicalTrials.gov ID: NCT00770861

Public ClinicalTrials.gov record NCT00770861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Prospective, Randomized, Double-blind, Placebo-Controlled, Dose-Titration Study of Nebivolol Monotherapy in Hispanic Patients With Stage 1 or Stage 2 Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of nebivolol monotherapy in Hispanic patients with stage 1 or stage 2 hypertension

Study identification

NCT ID
NCT00770861
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Forest Laboratories
Industry
Enrollment
277 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2008 (Type not available)
Primary completion
Nov 2009 (Actual)
Completion
Not listed
Last update posted
Jan 26, 2011

Started 2008

United States locations

U.S. sites
29
U.S. states
5
U.S. cities
22
Facility City State ZIP Site status
Forest Investigative Site Buena Park California 90620 —
Forest Investigative Site Chino California 91710 —
Forest Investigative Site Long Beach California 90806 —
Forest Investigative Site Los Angeles California 90057 —
Forest Investigative Site National City California 91950 —
Forest Investigative Site San Bernardino California 92404 —
Forest Investigative Site Temecula California 92591 —
Forest Investigative Site Tustin California 92780 —
Forest Investigative Site Coral Gables Florida 33134 —
Forest Investigative Site FL2 Hialeah Florida 33012 —
Forest Investigative Site Hialeah Florida 33012 —
Forest Investigative Site Hialeah Florida 33016 —
Forest Investigative Site Kissimmee Florida 34741 —
Forest Investigative Site Miami Florida 33014 —
Forest Investigative Site Miami Florida 33169 —
Forest Investigative Site Miami Florida 33183 —
Forest Investigative Site Pembroke Pines Florida 33024 —
Forest Investigative Site Pembroke Pines Florida 33027 —
Forest Investigative Site West Palm Beach Florida 33401 —
Forest Investigative Site Atlanta Georgia 30312 —
Forest Investigative Site Atlanta Georgia 30338 —
Forest Investigative Site New Windsor New York 12553 —
Forest Investigative Site The Bronx New York 10451 —
Forest Investigative Site Carrollton Texas 75006 —
Forest Investigative Site Corpus Christi Texas 78404 —
Forest Investigative Site Dallas Texas 75235 —
Forest Investigative Site El Paso Texas 79902 —
Forest Investigative Site San Antonio Texas 78224 —
Forest Investigative Site San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00770861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2011 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00770861 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →